B
Brown Retina Institute | Sant Antonio, TX
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Faricimab
APL-2
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
2 of 4 total trials
This study is designed to investigate treatment response in treatment-naïve underrepresented patients with diabetic macular edema (DME) who are treat...
Enrolling
Diabetic Macular Edema
Drug: Faricimab
ABBV-RGX-314 (also known as RGX-314) is being developed as a novel one-time gene therapy for the treatment of neovascular (wet) age-related macular d...
Enrolling
Wet Age-related Macular Degeneration
WetAMD
Biological: Aflibercept (EYLEA®)
Genetic: ABBV-RGX-314 Dose 2
Trial sponsors
A
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems